Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy.

Dear editor, I Stenotrophomonas maltophilia i infection is an increasing and feared complication in immunocompromised patients due to the intrinsic multidrug resistance and potential toxicity of conventional treatments [[1]]. At our knowledge, this is the first report of successful treatment of MDR I S. maltophilia i pneumonia with a cefiderocol-based regimen in a hematologic patient. [Extracted from the article]